Like ketoconazole treatment, Cyp51 knockout significantly suppressed CT26 tumor progression in the immunocompetent BALB/c mice (Fig. 6A,B), along with reduction of tumor-infiltrating Th17 population (Fig. 6C). This evidence concerns the gene DDX53 and neoplasm.